LYMPHIR 300 ug/2mL
denileukin diftitox-cxdl · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Citius Pharmaceuticals, Inc.
LYMPHIR is a injection, powder, lyophilized, for solution containing denileukin diftitox-cxdl at 300 ug/2mL, taken intravenous. Manufactured by Citius Pharmaceuticals, Inc..
Key Facts
- Brand Name
- LYMPHIR
- Generic Name
- denileukin diftitox-cxdl
- NDC Code (Product)
52658-7777- Manufacturer
- Citius Pharmaceuticals, Inc.
- Strength
- 300 ug/2mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761312
- Drug Class
- CD25-directed Cytotoxin [EPC]
- Marketing Start
- 03/01/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is LYMPHIR used for?
LYMPHIR contains denileukin diftitox-cxdl. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is LYMPHIR a controlled substance?
LYMPHIR is not classified as a controlled substance by the DEA.
What is the generic name for LYMPHIR?
The generic name for LYMPHIR is denileukin diftitox-cxdl. There are no other listed brand versions of denileukin diftitox-cxdl.
What is the NDC code for LYMPHIR 300 ug/2mL?
The NDC (National Drug Code) for LYMPHIR 300 ug/2mL is 52658-7777, listed by Citius Pharmaceuticals, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)